Danaher intends to acquire any common shares of Genetix that remain untendered through the compulsory acquisition provisions of the applicable UK companies legislation.
Statements in this document that are not strictly historical, including statements regarding the acquisition of the untendered shares, may constitute forward looking statements. There are a number of important factors that could cause actual events to differ materially from those suggested or indicated by such forward-looking statements. Information regarding factors that may cause actual results to differ materially from these forward-looking statements is available in Danaher's SEC filings, including Danaher's 2008 Annual Report on Form 10-K and Quarterly Report on Form 10-Q for the quarter ended October 2, 2009. These forward-looking statements speak only as of the date of this release and Danaher does not assume any obligation to update any forward-looking statement.
First Call Analyst:
SOURCE: Danaher Corporation
CONTACT: Matt R. McGrew, Vice President, Investor Relations of Danaher
Corporation, +1-202-828-0850, Fax: +1-202-828-0860
Web Site: http://www.danaher.com/